
Dropless regimens revolutionize postoperative eye care! Traditionally, topical antibiotics, steroids, and NSAIDs manage inflammation after anterior and posterior segment surgeries, but risks include toxicity, allergies, and patient noncompliance. Cataract and retina surgeons now favor intraoperative steroid and NSAID injections, reducing complications and waste. While intracameral dexamethasone implants show promise, limited data exists on dropless vitreoretinal surgery, highlighting the need for further research.
Like
Save
Share